NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Expression of PARP-1 in Multiple Sclerosis Patients
Expression of PARP-1 in Multiple Sclerosis Patients
CompletedNA
Sponsor: Sohag University
Conditions: Multiple Sclerosis
Interventions: Blood sampling
Countries: Egypt
This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 2021 to the end of December 2021. The study protocol will be approved by the Scientific Research Ethical Committee, Faculty of Medicine, Sohag University.
Eligibility overview
Sex: ALL
Age: 20 Years to 45 Years
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria Exclusion Criteria: * • Isolated optic neuritis.
Locations (1)
- Sohag, Egypt